Log In
Print
BCIQ
Print
Print this Print this
 

Tivorbex, indomethacin (Lower dose SoluMatrix indomethacin) (IP 940) (formerly submicron indomethacin, Tiforbex)

  Manage Alerts
Collapse Summary General Information
Company Iroko Pharmaceuticals LLC
DescriptionLower dose submicron formulation of the NSAID indomethacin using SoluMatrix fine particle technology
Molecular Target
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationPain
Indication DetailsTreat mild to moderate acute pain in adults
Regulatory Designation

U.S. - Undisclosed Review (Treat mild to moderate acute pain in adults)

Partner

iCeutica Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today